Considering the combination of CCL20 and TGF-β is associated with patients' worse prognoses and TGF-β plays a driver role in the cancer EMT 17, we raise that EMT is the predominant mechanism by which CCL20 promotes LUAD. Here, CCL20 is linked to cancer.